Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32968
Title: | The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis | Authors: | Wijtvliet, Veerle Plaeke, Philip ABRAMS, Steven HENS, Niel Gielis, Els Hellemans, Rachel De Winter, Benedicte Abramowicz, Daniel Ledeganck, Kristien |
Issue Date: | 2020 | Publisher: | OXFORD UNIV PRESS | Source: | NEPHROLOGY DIALYSIS TRANSPLANTATION, 35 (S3) , p. 190 -190 (Art N° TO009) | Abstract: | Background and Aims: Donor-derived cell-free DNA (dd-cfDNA) is actively studied as a non-invasive biomarker for the diagnosis of kidney allograft rejection, with conflicting results being reported. Therefore, we conducted a systematic review and meta-analysis to provide a clear overview of the potential value of dd-cfDNA to diagnose kidney rejection, and specifically antibody-mediated rejection (ABMR). Method: A systematic literature search was performed in Pubmed, Web of Science, and the Cochrane library using the search terms: "cell free DNA AND kidney transplantation". We included studies that 1) described dd-cfDNA fractions in blood of kidney allograft recipients; and 2) were published as English original research papers between January 1, 1994 and November 26, 2019. The methodological quality was assessed by the Methodological Index for Non-Randomized Studies (MINORS). Out of 287 hits, 55 duplicates were removed. 232 remaining abstracts were screened, leaving 36 articles for full-text review, of which 11 were included in a systematic review and data from 7 articles were synthesized in a meta-analysis. A weighted median of medians (WMM) (median with 95% confidence interval (CI) in squared brackets) was computed as a pooled estimate for the median dd-cfDNA fractions in different groups of patients. A meta-analysis was prespecified to be performed among following patient groups: 1) ABMR patients; 2) T-cell-mediated rejection (TCMR) patients; 3) stable patients; 4) patients without rejection at indication biopsy. The pooled ABMR group consisted of patient groups with pure ABMR and/or mixed ABMR/TCMR. Weighted median differences of medians (WMDM) were estimated for pairwise comparisons among the aforementioned groups, according to the approach proposed by McGrath et al. (2019). | Document URI: | http://hdl.handle.net/1942/32968 | ISSN: | 0931-0509 | e-ISSN: | 1460-2385 | ISI #: | WOS:000562392102167 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ordner1.pdf Restricted Access | Peer-reviewed author version | 243.23 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.